Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Plasmonic biosensors, Towards fully operative detection platforms for biomedical application and its potential for the diagnosis of autoimmune diseases

  • Giarola, Juliana Fatima|||0000-0002-2121-0328
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Lechuga, Laura M.|||0000-0001-5187-5358
In-vitro diagnostics (IVD) has become an in-demand area with a high-achievement transformation due to the expansion of new technologies. Technology has grown from time-consuming laboratory techniques to modern automated immunoassays and progressed with real-time sensing through the emergence of biosensor devices. Plasmonic biosensors are one of the most employed optical biosensors and stand out for their versatility and wide range of applications in diagnostic tests. One of the clinical diagnostics areas of growing interest is autoimmune diseases (AD), which have been increasingly prevalent worldwide. There is a rising demand for reliable and early AD diagnosis tools. This review highlights the main challenges for early AD diagnostics and the advanced plasmonic biosensors that have been exploited for AD biomarker detection, including brief descriptions of their analytical performance. Finally, the prospects and trends in this area are outlined, thinking about developing multiplexed platforms capable of addressing the multianalyte nature of one disease.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Design of subwavelength grating-based bimodal waveguide interferometric sensor in visible range for enhancing diagnostics sensitivity

  • Singh, Rukmani
  • Lechuga, Laura M.
  • García-Rupérez, Jaime|||0000-0002-2036-0084
[EN] The demand for point-of-care biosensors capable of rapid, accurate, and specific detection has grown significantly, particularly in the wake of the COVID-19 pandemic. Silicon photonics-based biosensors, based on evanescent wave sensing, have positioned as competitive candidates to meet these needs due to their high index contrast, compact size, high sensitivity and specificity, CMOS compatibility, and low cost. Among various configurations, the bimodal waveguide (BiMW) interferometer stands out for its high sensitivity and compact footprint. Meanwhile, subwavelength grating (SWG) waveguides offer enhanced sensitivity by providing a larger active sensing area compared to conventional waveguides. In this work, we propose integrating SWG waveguides with BiMW interferometers, using silicon nitride (Si3N4) as the guiding material in the visible wavelength range to improve sensing performance through enhanced sensitivity and compactness. Si3N4 offers advantages such as low scattering losses and chemical stability in biological environments, while operation in visible range increases compatibility with biological assays, making this approach novel. We present a comprehensive device design, optimization, and analysis of the SWG-based BiMW interferometer for refractive index sensing applications. Three-dimensional full vectorial simulations were conducted using the finite element method in COMSOL Multiphysics for the device design and optimizations. The proposed device demonstrates notable improvements in sensing performance, with an intrinsic bulk sensitivity of 0.1479 RIU/RIU, intrinsic surface sensitivity of 2.41 x 10(-4) RIU nm(-1), and a theoretical phase sensitivity of 1318 rad RIU-1 mm(-1), all achieved within a compact footprint., We acknowledge the financial support received for the TRYPLEX project (PDC2023-145891-I00), funded by MCIN/AEI/PERTE CHIP and the European Union NextGenerationEU, as well as from the PROMETEO Program (CIPROM/2022/14) from the Generalitat Valenciana. The ICN2 is supported by the Severo Ochoa Centres of Excellence program, grant CEX2021-001214-S, funded by MCIN/AEI/10.13039.501100011033. The nanoB2A is a consolidated research group ('Grup de Recerca') of the Generalitat de Catalunya and are supported by the Departament de Recerca i Universitats de la Generalitat de Catalunya (No. 2021 SGR 00456).
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

An α-helical peptide-based plasmonic biosensor for highly specific detection of α-synuclein toxic oligomers

  • Giarola, Juliana Fatima|||0000-0002-2121-0328
  • Santos Suárez, Jaime|||0000-0001-9045-7765
  • Estévez, M. Carmen|||0000-0003-3694-7186
  • Ventura, Salvador|||0000-0002-9652-6351
  • Pallarès i Goitiz, Irantzu|||0000-0002-8205-2060
  • Lechuga, Laura M.|||0000-0001-5187-5358
Background: α-Synuclein (αS) aggregation is the main neurological hallmark of a group of neurodegenerative disorders, collectively referred to as synucleinopathies, of which Parkinson's disease (PD) is the most prevalent. αS oligomers are elevated in the cerebrospinal fluid (CSF) of PD patients, standing as a biomarker for disease diagnosis. However, methods for early PD detection are still lacking. We have recently identified the amphipathic 22-residue peptide PSMα3 as a high-affinity binder of αS toxic oligomers. PSMα3 displayed excellent selectivity and reproducibility, binding to αS toxic oligomers with affinities in the low nanomolar range and without detectable cross-reactivity with functional monomeric αS. Results: In this work, we leveraged these PSMα3 unique properties to design a plasmonic-based biosensor for the direct detection of toxic oligomers under label-free conditions. Significance and novelty: We describe the integration of the peptide in a lab-on-a-chip plasmonic platform suitable for point-of-care measurements of αS toxic oligomers in CSF samples in real-time and at an affordable cost, providing an innovative biosensor for PD early diagnosis in the clinic.